Prezcobix label
Interaction Color Code
Clinical Bottom Line
Do not coadminister: Potential for increased irinotecan levels
Drug 1
Drug 2
Clinical Effects
Potential for increased risk of irinotecan adverse effects
Management
Discontinue DRV / c at least 1wk prior to starting irinotecan. Do not coadminister unless there are no therapeutic alternatives
Import ID
932
